CClinicalTrials.gg
CompletedNCT07798869Updated Sep 3, 2026

Genu Varum, Change of Direction, and Reactive Agility in Youth Football Players

An observational study in Genu Varum, sponsored by Akdeniz University. Completed at 1 site in Turkey (Türkiye). Open to male participants aged 13 Years to 19 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by Akdeniz University · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
34
Ages
13 Years to 19 Years
Sex
Male
01

Study summary

The goal of this observational study is to compare change-of-direction (COD) and reactive agility (RA) performance between football players with and without genu varum and to examine whether lower-limb alignment is associated with these performance measures.

The main questions it aims to answer are:

  1. Do football players with and without genu varum differ in COD and RA performance?
  2. Is lower-limb alignment associated with COD and RA performance in football players with and without genu varum?

Football players with and without genu varum will undergo assessments of lower-limb alignment, COD performance, and RA performance. The study will compare performance between the two groups and examine the relationship between lower-limb alignment and performance measures.

02

Conditions studied

  • Genu Varum

Browse trials for

Keywords

  • Genu varum
  • Lower-limb alignment
  • Football players
  • Soccer players
  • Change of direction
  • Knee alignment
  • Lower extremity alignment
03

Who can participate

Ages eligible
13 Years to 19 Years
Sexes eligible
Male
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

The study population consisted of male youth football players recruited from the academy of a professional football club based in Antalya, Türkiye. The football club competes in the Turkish Süper Lig, the highest tier of professional football in Türkiye.

Inclusion criteria

  • At least five years of football experience
  • Participation in football training at least five days per week
  • Voluntary participation in the study

Exclusion criteria

Exclusion Criteria:

  • History of lower extremity surgery
  • Current musculoskeletal injury affecting performance
04

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
34 participants (actual)
Patient registry
No

Groups and cohorts

  • Genu Varum Group

    Football players with genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.

  • Control Group

    Football players without genu varum who will be assessed for lower-limb alignment, change-of-direction performance, and reactive agility performance.

05

What researchers measure

Primary outcomes

  1. Change-of-direction performance

    Change-of-direction performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). The test consists of a 14.5-m running course with four changes of direction. Performance will be evaluated based on total completion time, with lower times indicating better change-of-direction performance.

    Time frame: at basline

  2. Reactive agility performance

    Reactive agility performance will be assessed using the SpeedCourt system (Globalspeed GmbH, Hemsbach, Germany). Participants will respond as quickly and accurately as possible to randomly presented visual stimuli and perform the required directional movements. Performance will be evaluated based on total completion time, with lower times indicating better reactive agility performance.

    Time frame: at basline

Secondary outcomes

  1. Intercondylar distance and intermalleolar distance

    Lower-limb alignment will be assessed by measuring intercondylar distance (ICD) and intermalleolar distance (IMD) in centimeters. ICD will be measured as the distance between the medial femoral condyles, and IMD as the distance between the medial malleoli, using a standardized measurement procedure.

    Time frame: at basline

06

Study locations

1 site
  • Akdeniz University
    Antalya, Turkey (Türkiye)
07

References and documents

Individual participant data

Plan to share: Undecided — Undecided

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07798869
Lead sponsor
Akdeniz University
Responsible party
Sponsor
First posted
Sep 1, 2026
Start date
Mar 1, 2025
Primary completion
Jun 1, 2025
Completion
Jun 12, 2025
Last update
Sep 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion